| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership | 
|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Chief Financial Officer | Common Stock | 51.9K | $651K | $12.55 | Jun 20, 2025 | Direct | 
| STAAR SURGICAL CO | Chief Financial Officer | Common Stock | 56.2K | $470K | $8.35 | Mar 12, 2025 | Direct | 
| STAAR SURGICAL CO | Chief Financial Officer | Restricted Stock Units | 16.3K | $136K | $8.35 | Mar 12, 2025 | Direct | 
| NeuroPace Inc | Chief Financial Officer | Stock Option (Right to Buy) | 88K | Jun 20, 2025 | Direct | ||
| BioRestorative Therapies, Inc. | Director | Stock Option | 52.6K | Feb 14, 2025 | Direct | ||
| STAAR SURGICAL CO | Chief Financial Officer | Common Stock Options | 21.9K | Mar 12, 2024 | Direct | ||
| STAAR SURGICAL CO | Chief Financial Officer | Performance Stock Units | 0 | Mar 7, 2025 | Direct | 
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role | 
|---|---|---|---|---|---|---|---|
| NPCE | NeuroPace Inc | Jun 20, 2025 | 2 | $0 | 4 | Jun 24, 2025 | Chief Financial Officer | 
| NPCE | NeuroPace Inc | Jun 20, 2025 | 0 | $0 | 3 | Jun 24, 2025 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Mar 12, 2025 | 2 | $0 | 4 | Mar 14, 2025 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Mar 7, 2025 | 6 | $0 | 4 | Mar 11, 2025 | Chief Financial Officer | 
| BRTX | BioRestorative Therapies, Inc. | Feb 14, 2025 | 1 | $0 | 4 | Feb 19, 2025 | Director | 
| STAA | STAAR SURGICAL CO | Mar 12, 2024 | 2 | $0 | 4 | Mar 14, 2024 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Mar 7, 2024 | 1 | $0 | 4 | Mar 11, 2024 | Chief Financial Officer | 
| BRTX | BioRestorative Therapies, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Director | 
| STAA | STAAR SURGICAL CO | Aug 10, 2023 | 2 | -$112K | 4 | Aug 11, 2023 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Jun 6, 2023 | 2 | -$109K | 4 | Jun 7, 2023 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Mar 10, 2023 | 3 | -$16.4K | 4 | Mar 10, 2023 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Mar 7, 2023 | 2 | $37.7K | 4 | Mar 8, 2023 | Chief Financial Officer | 
| BRTX | BioRestorative Therapies, Inc. | Feb 17, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director | 
| BRTX | BioRestorative Therapies, Inc. | Nov 3, 2022 | 2 | $0 | 4 | Nov 4, 2022 | Director | 
| STAA | STAAR SURGICAL CO | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Mar 7, 2022 | 2 | $0 | 4 | Mar 8, 2022 | Chief Financial Officer | 
| BRTX | BioRestorative Therapies, Inc. | Nov 4, 2021 | 1 | $0 | 4 | Nov 8, 2021 | Director | 
| BRTX | BioRestorative Therapies, Inc. | Nov 4, 2021 | 0 | $0 | 3 | Nov 8, 2021 | Director | 
| STAA | STAAR SURGICAL CO | Sep 16, 2021 | 1 | -$714K | 4 | Sep 17, 2021 | Chief Financial Officer | 
| STAA | STAAR SURGICAL CO | Aug 10, 2021 | 2 | -$351K | 4 | Aug 12, 2021 | Chief Financial Officer |